Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and effective. The drug was associated with fewer major bleeding events and fewer recurrent ...
Dec 3, 2018
0
0
Deep vein thrombosis (DVT) is a common medical condition in which blood clots develop in the deep veins of the body, often in the legs, thigh or pelvis. These clots can break loose and travel to the lungs and can cause a ...
Jul 16, 2018
0
0
(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA Internal Medicine.
Nov 7, 2017
0
0
People who sustain a traumatic brain injury (TBI) are at high risk for developing deep vein thrombosis (DVT) and pulmonary embolism (PE). PE is a leading cause of death in these patients. But blood-thinning medications started ...
Jul 21, 2016
0
2
(HealthDay)—Patients with persistent atrial fibrillation (AF) from the onset (PsAFonset) have distinct demographics and poorer clinical outcome, according to a study published online March 23 in JACC: Clinical Electrophysiology.
Mar 24, 2016
0
3
Ultrasound is the most common technique for detecting a widespread cardiovascular condition: blood clots in the leg, otherwise known as deep vein thrombosis (DVT). But there's a little known—yet serious—risk to using ...
Jan 29, 2016
0
0
Among patients undergoing major cancer operations, the preoperative use of blood-thinning drugs such as heparin does not increase rates of major bleeding or transfusions, and is associated with a decreased risk of blood clots, ...
Dec 15, 2015
0
0
Edoxaban (trade name: Lixiana) has been approved since June 2015 for two therapeutic indications in adults: on the one hand, for prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation (NVAF) ...
Nov 5, 2015
0
6
Late recurrence of atrial fibrillation (AF) is not reduced in patients whose pulmonary vein isolation (PVI) treatment incorporates the addition of adenosine triphosphate (ATP), according to results of the UNDER-ATP trial.
Aug 30, 2015
0
3
Potentially fatal blood clots account for thousands of emergency room visits each year and often those patients are admitted to the hospital, treated with an injectable anticoagulant and monitored for a few days. In companion ...
Jul 16, 2015
0
6
